G. Montagna Et Al. , "Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study," Journal of Clinical Oncology , 2024
Montagna, G. Et Al. 2024. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study. Journal of Clinical Oncology .
Montagna, G., Laws, A., Ferrucci, M., Mrdutt, M. M., Sun, S. X., BADEMLER, S., ... Balbaloglu, H.(2024). Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study. Journal of Clinical Oncology .
Montagna, Giacomo Et Al. "Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study," Journal of Clinical Oncology , 2024
Montagna, Giacomo Et Al. "Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study." Journal of Clinical Oncology , 2024
Montagna, G. Et Al. (2024) . "Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study." Journal of Clinical Oncology .
@article{article, author={Giacomo Montagna Et Al. }, title={Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study}, journal={Journal of Clinical Oncology}, year=2024}